Mylan Completes Acquisition of Merck’s Generics Business

19:15 PM | October 17, 2007 | Chemical Week Editorial Staff

Mylan Laboratories (Canonsburg, PA) has completed the previously announced acquisition of Merck KGaA’s generic drugs business for €4.9 billion ($6.7 billion) in cash. The companies signed a definitive...